Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Revealing Individual Neuroanatomical Heterogeneity in Alzheimer’s Disease

View ORCID ProfileSerena Verdi, View ORCID ProfileSeyed Mostafa Kia, View ORCID ProfileKeir Yong, View ORCID ProfileDuygu Tosun, View ORCID ProfileJonathan M. Schott, View ORCID ProfileAndre F. Marquand, View ORCID ProfileJames H. Cole, the Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/2022.06.30.22277053
Serena Verdi
1Centre for Medical Image Computing, Medical Physics and Biomedical Engineering, University College London, London, UK
2Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Serena Verdi
Seyed Mostafa Kia
3Donders Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, 6525EN, the Netherlands
4Department of Psychiatry, University Medical Centre Utrecht, Utrecht, 3584CX, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seyed Mostafa Kia
Keir Yong
2Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Keir Yong
Duygu Tosun
6Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Duygu Tosun
Jonathan M. Schott
2Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan M. Schott
Andre F. Marquand
3Donders Centre for Cognitive Neuroimaging, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, 6525EN, the Netherlands
5Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, 6525EN, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andre F. Marquand
James H. Cole
1Centre for Medical Image Computing, Medical Physics and Biomedical Engineering, University College London, London, UK
2Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James H. Cole
  • For correspondence: james.cole{at}ucl.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Alzheimer’s disease is clinically heterogeneous, in symptom profiles, progression rates and outcomes. This clinical heterogeneity is linked to underlying neuroanatomical heterogeneity. To explore this, we employed the emerging technique of neuroanatomical normative modelling to index regional patterns of variability in cortical thickness in individual patients from the large multi-site Alzheimer’s Disease Neuroimaging Initiative. We aimed to characterise individual differences and outliers in cortical thickness in patients with Alzheimer’s disease, people with mild cognitive impairment and cognitively normal controls. Furthermore, we assessed the relationships between cortical thickness heterogeneity and cognitive function, amyloid-beta, tau, ApoE genotype. Finally, we examined whether individual neuroanatomical normative maps were predictive of conversion from mild cognitive impairment to diagnosed Alzheimer’s disease. Data on cortical thickness from the 148 brain regions of the Destrieux FreeSurfer atlas was obtained from T1-weighted MRI scans of 1492 participants scanned at 62 different sites. A neuroanatomical normative model was developed to index normal cortical thickness distributions using a separate healthy reference dataset (n= 33,072), employing hierarchical Bayesian regression to predict cortical thickness per region using age and sex. These regional normative models were then fine-tuned to the ADNI dataset after which cortical thickness z-scores per region were calculated, resulting in a z-score ‘map’ for each participant. Regions with z-scores < -1.96 were classified as outliers. Patients with Alzheimer’s disease had a median of 12 outlier regions out of a possible 148. Individual patterns of outlier regions were highly variable, with the highest overlap in the parahippocampal gyrus at only 47% of patients. For 62 regions, over 90% of these patients had cortical thicknesses within the normal range. Patients with Alzheimer’s disease had significantly more outlier regions than people with mild cognitive impairment or controls [F(2, 1022) = 95.39), P = 2.0 x ×10−16]. They were also statistically more dissimilar to each other than were people with mild cognitive impairment or cognitive normal controls [F(2, 1024) = 209.42, P = 2.2×10−16]. Having a greater number of outlier regions was associated with worse cognitive function, CSF protein concentrations and an increased risk of converting from mild cognitive impairment to Alzheimer’s disease within three years (HR =1.028, 95% CI[1.016,1.039], P =1.8 ×10−16). Individualised normative maps of cortical thickness highlight the heterogeneity of Alzheimer’s effects on the brain. Regional outlier estimates have the potential to be a marker of disease and could be used to track an individual’s disease progression or treatment response in clinical trials.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the EPSRC-funded UCL Centre for Doctoral Training in Intelligent, Integrated Imaging in Healthcare (i4health) (EP/S021930/1) and the Department of Health's National Institute for Health Research funded University College London Hospitals Biomedical Research Centre. In addition, A.F.M. gratefully acknowledges funding from the Dutch Organization for Scientific Research via a VIDI fellowship (grant number 016.156.415); J.M.S. acknowledges the support of Alzheimer's Research UK, Brain Research UK, Weston Brain Institute, Medical Research Council and the British Heart Foundation. K.Y. is an Etherington PCA Senior Research Fellow and is funded by the Alzheimer's Society, grant number 453 (AS-JF-18-003).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study used only openly available human data that are located at: https://adni.loni.usc.edu/methods/documents/

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Statistical analysis scripts are available on GitHub (https://github.com/serenaverdi/ADNI_normative-modelling). The neuroanatomical normative model was generated using the PCNtoolkit software package (https://github.com/amarquand/PCNtoolkit). ADNI data used in this study are publicly available and can be requested following ADNI Data Sharing and Publications Committee guidelines: http://adni.loni.usc.edu/data-samples/access-data/

  • Abbreviations

    ADNI =
    Alzheimer’s Disease Neuroimaging Initiative;
    AD =
    Alzheimer’s disease;
    ApoE =
    Apolipoprotein E;
    CSF=
    Cerebrospinal fluid;
    CN =
    cognitively normal;
    MCI =
    Mild Cognitive impairment;
    MMSE=
    Mini-Mental State Examination
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted July 03, 2022.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Revealing Individual Neuroanatomical Heterogeneity in Alzheimer’s Disease
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Revealing Individual Neuroanatomical Heterogeneity in Alzheimer’s Disease
    Serena Verdi, Seyed Mostafa Kia, Keir Yong, Duygu Tosun, Jonathan M. Schott, Andre F. Marquand, James H. Cole, the Alzheimer’s Disease Neuroimaging Initiative
    medRxiv 2022.06.30.22277053; doi: https://doi.org/10.1101/2022.06.30.22277053
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Revealing Individual Neuroanatomical Heterogeneity in Alzheimer’s Disease
    Serena Verdi, Seyed Mostafa Kia, Keir Yong, Duygu Tosun, Jonathan M. Schott, Andre F. Marquand, James H. Cole, the Alzheimer’s Disease Neuroimaging Initiative
    medRxiv 2022.06.30.22277053; doi: https://doi.org/10.1101/2022.06.30.22277053

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Neurology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)